SAM 2025

Back
27 - 29 March 2025 Bilbao, Spain

Taking a closer look to the first EMA-approved omalizumab biosimilar in Chronic Spontaneous Urticaria

Friday 28 Mar, 12:30 PM - 13:00 PM Bilbao, Spain